BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Novo-Veleiro I, Alvela-Suárez L, Chamorro AJ, González-Sarmiento R, Laso FJ, Marcos M. Alcoholic liver disease and hepatitis C virus infection. World J Gastroenterol 2016; 22(4): 1411-1420 [PMID: 26819510 DOI: 10.3748/wjg.v22.i4.1411]
URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1411.htm
Number Citing Articles
1
Jonathan Chow, Zsuzsa Márka, Imre Bartos, Szabolcs Márka, Jonathan C. Kagan. Environmental Stress Causes Lethal Neuro-Trauma during Asymptomatic Viral InfectionsCell Host & Microbe 2017; 22(1): 48 doi: 10.1016/j.chom.2017.06.010
2
Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)Annals of Hepatology 2019; 18(3): 518 doi: 10.1016/j.aohep.2019.04.005
3
Baozhang Shi, Jinqiang Qian, Hongyue Miao, Shuo Zhang, Yue Hu, Puqing Liu, Liping Xu. Mulberroside A ameliorates CCl4‐induced liver fibrosis in mice via inhibiting pro‐inflammatory responseFood Science & Nutrition 2023; 11(6): 3433 doi: 10.1002/fsn3.3333
4
Xinyi Jiang, Hyun Jin Song, Ching-Yuan Chang, Debbie L. Wilson, Wei-Hsuan Lo-Ciganic, Haesuk Park. Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis CMedical Care 2023; 61(8): 505 doi: 10.1097/MLR.0000000000001870
5
Shazia Tabassum Hakim, Cayatineto HW. Prospective approaches to target bovine viral diarrhea virus and hepatitis C virus using miRNA-based inhibitorsJournal of Human Virology & Retrovirology 2024; 11(1): 36 doi: 10.15406/jhvrv.2024.11.00278
6
Benjamin J. Mahoney, Kenneth L. Morford, Emma T. Biegacki, Jeanette M. Tetrault. Hepatitis C virus and integrated care for substance use disordersClinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000241
7
F. Roesch-Dietlen, M. González-Santes, Y.J. Sánchez-Maza, F. Díaz-Roesch, A.D. Cano-Contreras, M. Amieva-Balmori, K.R. García-Zermeño, L. Salgado-Vergara, J.M. Remes-Troche, S. Ortigoza-Gutiérrez. Influence of socioeconomic and cultural factors in the etiology of cirrhosis of the liverRevista de Gastroenterología de México (English Edition) 2021; 86(1): 28 doi: 10.1016/j.rgmxen.2020.01.004
8
P. V. AshaRani, Mohamed Zakir Karuvetil, Tan Yeow Wee Brian, Pratika Satghare, Kumarasan Roystonn, Wang Peizhi, Laxman Cetty, Noor Azizah Zainuldin, Mythily Subramaniam. Prevalence and Correlates of Physical Comorbidities in Alcohol Use Disorder (AUD): a Pilot Study in Treatment-Seeking PopulationInternational Journal of Mental Health and Addiction 2023; 21(4): 2508 doi: 10.1007/s11469-021-00734-5
9
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller. Subclinical versus advanced forms of alcohol-related liver disease: Need for early detectionClinical and Molecular Hepatology 2023; 29(1): 1 doi: 10.3350/cmh.2022.0017
10
Natalia A. Osna, Rakesh Bhatia, Christopher Thompson, Surinder K. Batra, Sushil Kumar, Yeonhee Cho, Gyongyi Szabo, Patricia E. Molina, Steven A. Weinman, Murali Ganesan, Kusum K. Kharbanda. Role of non-Genetic Risk Factors in Exacerbating Alcohol-related organ damageAlcohol 2020; 87: 63 doi: 10.1016/j.alcohol.2020.05.002
11
Fabiane Mateus Siqueira, Vinicius Lins Ferreira, Helena Hiemisch Lobo Borba, Roberto Pontarolo. Quality of life of Brazilian chronic hepatitis C patients treated with interferon-free therapiesRevista do Instituto de Medicina Tropical de São Paulo 2018; 60(0) doi: 10.1590/s1678-9946201860072
12
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatmentWorld Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
13
Murali Ganesan, Allison Eikenberry, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Role of alcohol in pathogenesis of hepatitis B virus infectionWorld Journal of Gastroenterology 2020; 26(9): 883-903 doi: 10.3748/wjg.v26.i9.883
14
Koichiro Ohashi, Michael Pimienta, Ekihiro Seki. Alcoholic liver disease: A current molecular and clinical perspectiveLiver Research 2018; 2(4): 161 doi: 10.1016/j.livres.2018.11.002
15
Pablo Muriel. Hepatic Fibrosis2022; : 127 doi: 10.1016/B978-0-323-99764-5.00008-1
16
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda. Treatment options for alcoholic and non-alcoholic fatty liver disease: A reviewWorld Journal of Gastroenterology 2017; 23(36): 6549-6570 doi: 10.3748/wjg.v23.i36.6549
17
Suyan G.R. dos Santos, Angelo A. Mattos, Marcela M. Guimarães, Bibiana de S. Boger, Gabriela P. Coral. Alcohol Consumption Influences Clinical Outcome in Patients Admitted to a Referral Center for Liver DiseaseAnnals of Hepatology 2018; 17(3): 470 doi: 10.5604/01.3001.0011.7391
18
Silvia Andaloro, Fabrizio Mancuso, Luca Miele, Giovanni Addolorato, Antonio Gasbarrini, Francesca Romana Ponziani. Effect of Low-Dose Alcohol Consumption on Chronic Liver DiseaseNutrients 2024; 16(5): 613 doi: 10.3390/nu16050613
19
Zixiong Zhou, Jing Qi, Jong-Won Kim, Myung-jo You, Chae Woong Lim, Bumseok Kim. AK-1, a Sirt2 inhibitor, alleviates carbon tetrachloride-induced hepatotoxicity in vivo and in vitroToxicology Mechanisms and Methods 2020; 30(5): 324 doi: 10.1080/15376516.2020.1729915
20
Mariya S. Pravdivtseva, Oleg B. Shevelev, Vadim V. Yanshole, Mikhail P. Moshkin, Igor V. Koptyug, Andrey E. Akulov. In Vitro 1H NMR Metabolic Profiles of Liver, Brain, and Serum in Rats After Chronic Consumption of AlcoholApplied Magnetic Resonance 2021; 52(6): 661 doi: 10.1007/s00723-021-01338-x
21
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV InfectionJournal of Clinical Medicine 2021; 10(15): 3218 doi: 10.3390/jcm10153218
22
Neil D. Theise, Henry Charles Bodenheimer, Maria Guido. Macsween's Pathology of the Liver2018; : 372 doi: 10.1016/B978-0-7020-6697-9.00006-6
23
Sasha Hermosa, Stelliana Goutzamanis, Joseph Doyle, Peter Higgs. Reducing alcohol-related harm in people recently treated for hepatitis CAustralian Journal of Primary Health 2019; 25(3): 193 doi: 10.1071/PY19074
24
Hideki Fujii, Naoki Nishimoto, Seiko Yamaguchi, Osamu Kurai, Masato Miyano, Wataru Ueda, Hiroko Oba, Tetsuya Aoki, Norifumi Kawada, Kiyotaka Okawa. The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional studyBMC Public Health 2016; 16(1) doi: 10.1186/s12889-016-3053-6
25
James C. Barton, J. Clayborn Barton, Paul C. Adams. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotesAnnals of Hepatology 2019; 18(2): 354 doi: 10.1016/j.aohep.2018.11.005
26
Lin Zhu, Hai-Di Li, Jie-Jie Xu, Juan-Juan Li, Miao Cheng, Xiao-Ming Meng, Cheng Huang, Jun Li. Advancements in the Alcohol-Associated Liver Disease ModelBiomolecules 2022; 12(8): 1035 doi: 10.3390/biom12081035
27
Akshata Moghe, Shirish S. Barve, Craig J. McClain, Swati Joshi-Barve. Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCVCellular and Molecular Gastroenterology and Hepatology 2018; 5(2): 163 doi: 10.1016/j.jcmgh.2017.11.009
28
Wen-Jun Wang, Peng Xiao, Hong-Qin Xu, Jun-Qi Niu, Yan-Hang Gao. Growing burden of alcoholic liver disease in China: A reviewWorld Journal of Gastroenterology 2019; 25(12): 1445-1456 doi: 10.3748/wjg.v25.i12.1445
29
F. Roesch-Dietlen, M. González-Santes, Y.J. Sánchez-Maza, F. Díaz-Roesch, A.D. Cano-Contreras, M. Amieva-Balmori, K.R. García-Zermeño, L. Salgado-Vergara, J.M. Remes-Troche, S. Ortigoza-Gutiérrez. Influencia de los factores socioeconómicos y culturales en la etiología de la cirrosis hepáticaRevista de Gastroenterología de México 2021; 86(1): 28 doi: 10.1016/j.rgmx.2020.01.002
30
Mark Thursz, Antoni Gual, Caroline Lackner, Philippe Mathurin, Christophe Moreno, Laurent Spahr, Martina Sterneck, Helena Cortez-Pinto. EASL Clinical Practice Guidelines: Management of alcohol-related liver diseaseJournal of Hepatology 2018; 69(1): 154 doi: 10.1016/j.jhep.2018.03.018
31
Haesuk Park, Xinyi Jiang, Hyun Jin Song, Vincent Lo Re, Lindsey M. Childs‐Kean, Wei‐Hsuan Lo‐Ciganic, Robert L. Cook, David R. Nelson. The Impact of Direct‐Acting Antiviral Therapy on End‐Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use DisordersHepatology 2021; 74(2): 566 doi: 10.1002/hep.31732
32
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapyToxicology Reports 2021; 8: 376 doi: 10.1016/j.toxrep.2021.02.010
33
Ashakumary Lakshmikuttyamma, Sidhartha D. Ray, Abigail Kay. Side Effects of Drugs Annual 2016;  doi: 10.1016/bs.seda.2016.08.023
34
Laura Llamosas-Falcón, Kevin D. Shield, Maya Gelovany, Jakob Manthey, Jürgen Rehm. Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic reviewSubstance Abuse Treatment, Prevention, and Policy 2020; 15(1) doi: 10.1186/s13011-020-00287-1
35
Paula Chaves Mari, Reema Gulati, Philip Fragassi. Adolescent Hepatitis C: Prevalence, Impact, and Management ChallengesAdolescent Health, Medicine and Therapeutics 2021; : 45 doi: 10.2147/AHMT.S263864
36
Kairi Mansberg, Karin Kull, Riina Salupere, Tiina Prükk, Benno Margus, Toomas Kariis, Triin Remmel, Külliki Suurmaa, Kristi Ott, Krista Jaago, Jelena Šmidt. A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in EstoniaMedicina 2018; 54(1): 9 doi: 10.3390/medicina54010009
37
Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada. Hepatitis B virus infection and alcohol consumptionWorld Journal of Gastroenterology 2017; 23(15): 2651-2659 doi: 10.3748/wjg.v23.i15.2651
38
Jiadi Wu, Daqiang Wu, Kelong Ma, Tianming Wang, Gaoxiang Shi, Jing Shao, Changzhong Wang, Guiming Yan. Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1/IL-1β signaling pathwayJournal of Leukocyte Biology 2020; 108(1): 199 doi: 10.1002/JLB.3MA0120-325RR
39
Lufuno Ratshisusu, Omphile E. Simani, Jason T. Blackard, Selokela G. Selabe. The Impact of Drugs and Substance Abuse on Viral Pathogenesis—A South African PerspectiveViruses 2024; 16(6): 971 doi: 10.3390/v16060971
40
Phoenix Fung, Nikolaos Pyrsopoulos. Emerging concepts in alcoholic hepatitisWorld Journal of Hepatology 2017; 9(12): 567-585 doi: 10.4254/wjh.v9.i12.567
41
Vatsalya Vatsalya, Ruchita Agrawal, Jane Frimodig, Shweta Srivastava, Melanie L. Schwandt. Dysregulation in Plasma ω3 Fatty Acids Concentration and Serum Zinc in Heavy Alcohol-Drinking HCV PatientsAdvances in Virology 2020; 2020: 1 doi: 10.1155/2020/7835875